• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    SMS Pharmaceuticals Limited — Updates, 01-08-2026: Press Release

    01-08-2026 | 05:06 pm

    SMS Pharma's Q1 revenue rose 6% YoY to ₹207 Cr, with PAT up 8% to ₹20.20 Cr, maintaining 20% EBITDA. Growth was driven by high-value APIs. The ₹280 Cr capex is progressing, alongside a ₹50 Cr investment in peptide R&D for a future product pipeline.

    No comments yet. Be the first to comment!

    All announcements from SMS Pharmaceuticals Limited